<p dir="ltr">Colesevelam possesses antidiabetic properties, which could potentiate sulphonylurea or insulin‐induced hypoglycemia; clinically significant hypoglycemia, as a side effect to bile acid sequestrants, may be under‐recognized in clinical practice.</p>
History
Author affiliation
University of Leicester
College of Life Sciences
Medical Sciences